Related Experiment Video
Updated: Aug 31, 2025

Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos
Published on: September 9, 2015
Dominant Negative TRAF3 Variant With Recurrent Mycobacterium abscessus Infection and Bronchiectasis
Mei Fong Liew1, Hui Fang Lim2, Mui Cheng Liang3
1FAST and Chronic Programmes, Alexandra Hospital, National University Health System, Singapore, Singapore.
Abstract:
Host factors leading to pulmonary nontuberculous mycobacteria (PNTM) disease are poorly understood compared with disseminated NTM disease, which is linked to the interleukin 12-interferon gamma signaling pathway. We investigated the tumor necrosis factor receptor associated factor 3 (TRAF3) R338W variant in a patient with recurrent PNTM infection, demonstrating TRAF3- and TNF-α-deficient phenotypes via ex vivo immune and cloning-transfection cellular studies.
Insights
Host factors for pulmonary nontuberculous mycobacteria (PNTM) disease remain unclear. This study identified a tumor necrosis factor receptor associated factor 3 (TRAF3) variant linked to recurrent PNTM infections, revealing TRAF3 and TNF-α deficiencies.
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- Pulmonary nontuberculous mycobacteria (PNTM) disease pathogenesis is poorly understood.
- Disseminated nontuberculous mycobacteria (NTM) disease is associated with the interleukin-12/interferon-gamma (IL-12/IFN-γ) signaling pathway.
- Host genetic factors influencing PNTM susceptibility require further investigation.
Purpose of the Study:
- To investigate the role of the tumor necrosis factor receptor associated factor 3 (TRAF3) R338W variant in a patient with recurrent PNTM infection.
- To elucidate the impact of this variant on immune function and susceptibility to PNTM.
Main Methods:
- Genetic analysis of a patient with recurrent PNTM.
- Ex vivo immune studies to assess cellular responses.
- Cloning-transfection cellular studies to investigate protein function.
Main Results:
- Identification of the TRAF3 R338W variant in the patient.
- Demonstration of TRAF3-deficient and tumor necrosis factor-alpha (TNF-α)-deficient phenotypes.
- Evidence linking the variant to impaired immune responses.
Conclusions:
- The TRAF3 R338W variant may contribute to susceptibility to recurrent PNTM disease.
- TRAF3 and TNF-α signaling are critical for host defense against PNTM.
- Further research into genetic host factors is warranted for understanding PNTM pathogenesis.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

